Post

New research · Infectious Disease
Hepatology communications · 23h
ReviewHepatology communications · 2026

Contemporary global epidemiology of cirrhosis.

Preenapun Saokhieo, Thanida Auttapracha, Pojsakorn Danpanichkul … Karn Wijarnpreecha
Read paper
Infectious DiseaseReview

Cirrhosis and chronic liver disease caused ~1.4 million deaths globally in 2021.

Contemporary global epidemiology of cirrhosis.

Preenapun Saokhieo et al. · Hepatology communications · 2026
Background

Cirrhosis remains a major global cause of morbidity and mortality, with rapidly evolving etiologic drivers.

~1.4 million deaths
Results
this many people died worldwide from liver disease in 2021
More results

Although age-standardized mortality rates have declined in many regions, the absolute burden continues to rise due to population growth and aging.

More results

High-sociodemographic index (SDI) regions exhibit lower mortality but increasing prevalence, reflecting improved survival and expanding metabolic risk, whereas low- and lower-middle-SDI regions continue to experience high mortality.

“
Conclusion

Addressing the global burden of cirrhosis will require sustained public health investment focused on viral hepatitis elimination, alcohol-associated harm reduction, metabolic risk management, and equitable access to early detection and care.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
98%
nearly all refugee children received their missing childhood vaccines after arriving in Switzerland
Study
77.8%
77.8% of patients achieved a strong reduction in hepatitis D virus RNA.
Study
3.23 × 10 -3 to 7.33 × 10 -3
Hazard Quotient values for children consuming lettuce were below safety thresholds.
Guideline
13
total guidance points for managing a chronic lung condition
Cohort Study
182.1 per 100,000 population
this was the highest number of COVID-19 deaths per 100,000 food workers
Study
90.5% (38/42)
most isolates were resistant to ampicillin and amoxicillin-sulbactam
Cohort Study
AHR, 1.09 [95% CI, 0.94-1.27]
similar risk of death for E. coli blood infections resistant vs susceptible to antibiotic
Cohort Study
10 years
Elevated immune responses were observed up to 10 years before Crohn's disease diagnosis.